Puma Biotechnology (PBYI) Operating Expenses (2017 - 2025)
Historic Operating Expenses for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $44.9 million.
- Puma Biotechnology's Operating Expenses fell 2319.59% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.4 million, marking a year-over-year decrease of 1550.08%. This contributed to the annual value of $199.5 million for FY2024, which is 172.17% down from last year.
- Per Puma Biotechnology's latest filing, its Operating Expenses stood at $44.9 million for Q3 2025, which was down 2319.59% from $45.8 million recorded in Q2 2025.
- Puma Biotechnology's 5-year Operating Expenses high stood at $78.0 million for Q1 2021, and its period low was $42.0 million during Q1 2025.
- For the 5-year period, Puma Biotechnology's Operating Expenses averaged around $52.2 million, with its median value being $48.5 million (2021).
- As far as peak fluctuations go, Puma Biotechnology's Operating Expenses crashed by 4042.4% in 2022, and later surged by 2299.97% in 2024.
- Over the past 5 years, Puma Biotechnology's Operating Expenses (Quarter) stood at $48.5 million in 2021, then grew by 14.7% to $55.7 million in 2022, then grew by 3.09% to $57.4 million in 2023, then decreased by 20.33% to $45.7 million in 2024, then dropped by 1.77% to $44.9 million in 2025.
- Its last three reported values are $44.9 million in Q3 2025, $45.8 million for Q2 2025, and $42.0 million during Q1 2025.